To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Cardiovascular Catheters Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Global sales of cardiovascular catheters are predicted to increase at a healthy CAGR of 7% during the next 10 years. The global cardiovascular catheters market is valued at US$ 21.44 billion in 2023 and is thus projected to reach US$ 42.18 billion by the end of 2033.
A catheter is a small tube with various uses that is manufactured from medical-grade materials. Medical devices called catheters can be implanted within the body to treat illnesses or carry out surgeries. The act of inserting a cardiac catheter into a heart chamber or blood artery is known as cardiac catheterization. This is carried out for both diagnostic and therapeutic reasons.
Coronary catheterization, which involves inserting a catheter into the coronary arteries to check for myocardial infarctions and coronary artery disease, is a typical instance of cardiac catheterization. The coronary vessels can be examined during a diagnostic technique called coronary angiography.
In complicated lesions and chronic total occlusion percutaneous coronary procedures (CTO PCIs), coronary microcatheters (MCs) are valuable tools. By improving the penetration of guidewires and enabling guidewire exchanges, they considerably raise success rates.
Cardiovascular catheters are segmented into cardiovascular therapeutic catheters and cardiovascular diagnostic catheters. Cell, medication, or ablation therapy can all be administered using therapeutic catheters. Atrial and ventricular arrhythmias are treated through the ablation of cardiac tissue. Global demand for cardiovascular therapeutic catheters is expected to rise at a CAGR of 7.5% from 2023 to 2033.
The examination of individuals with known or suspected heart disease often involves diagnostic cardiac catheterization or diagnostic catheters. It is commonly used to evaluate the severity and presence of congenital heart disease, heart valve issues, coronary artery disease, and abnormalities with the heart muscle. Global sales of cardiovascular diagnostic catheters are anticipated to evolve at a CAGR of 6% during the forecast period.
There are several types of catheters available based on their use such as intravascular catheters, normal balloon catheters, cutting balloon catheters, stent graft balloon catheters, scoring balloon catheters, drug-eluting balloon catheters, intravascular ultrasound (IVUS) catheters, electrophysiology catheters, cardiovascular angiographic catheters, and more. They are used in cardiac catheterization procedures but according to their need, based on the condition of the disease.
Rapidly increasing senior population and rising cases of cardiovascular disorders are expected to boost the sales of cardiovascular catheters during the projected period. Technological advancements and rising investments in R&D are also expected to boost sales growth.
Report Attributes |
Details |
Cardiovascular Catheters Market Size (2023E) |
US$ 21.44 Billion |
Forecasted Market Value (2033F) |
US$ 42.18 Billion |
Global Market Growth Rate (2023 to 2033) |
7% CAGR |
China Market Growth Rate (2023 to 2033) |
11% CAGR |
Japan Market Growth Rate (2023 to 2033) |
4% CAGR |
Germany Market Growth Rate (2023 to 2033) |
4.5% CAGR |
Canada Market Growth Rate (2023 to 2033) |
6% CAGR |
Key Companies Profiled |
|
“Increasing Need for Cardiovascular Procedures”
Cardiac catheterization is a minimally-invasive procedure that aids in the diagnosis of diseases that cause fatigue, shortness of breath, and other symptoms such as chest pain. The demand for cardiac catheters and cardiac guidewires is projected to increase during the forecast period due to the rising prevalence of chronic heart diseases worldwide.
Increasing prevalence of heart illnesses (such as cardiomyopathy and stroke) is the main contributor to heart-related mortality. Cardiovascular diseases are among the most prevalent conditions worldwide. The demand for cardiovascular catheter devices is anticipated to increase as a result of the rising prevalence of coronary illnesses and the consequent rise in the demand for early diagnosis and treatment.
“Continuous Advancements in Cardiac Diagnosis & Treatment Devices”
Over the coming years, it is projected that several respective governments are focusing on providing citizens with high-quality healthcare facilities, continuous technological improvements, and the rapidly developing medical sector would all have a beneficial effect on catheterization and cardiovascular diagnosis device sales.
Recent advancements in cardiovascular monitoring and diagnosis methods have led to the introduction of advanced physiological bio-signals. Anomalies in cardiovascular parameters can be detected more easily when the diagnosis is automated.
To improve the effectiveness of minimally-invasive interventional procedures, market players are pushing their research efforts on the development of cardiac catheters. The introduction of artificial intelligence (AI) is one of the advancements in this field.
Thus, Fact.MR, a market research and competitive intelligence provider estimates that the introduction of modern technologies and increasing cases of cardiovascular disorders (CVDs) are boosting the growth of the cardiac catheters market.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
“Side Effects Associated with Catheters”
Catheters are inserted temporarily or permanently into different parts of the body. The risk of infection exists whenever a foreign material is ingested.
For instance :
These illnesses are known as urinary tract infections or UTIs. As a result, the risk of infections may cause patients to adopt catheters less frequently, which would affect sales growth. Also, the high costs of surgeries and unfavourable reimbursement policies are hampering the demand for catheters.
“Presence of Key Market Players and Advanced Healthcare Infrastructure”
The United States is predicted to lead the North American cardiovascular catheters market, due to the high prevalence of cardiac illnesses, the high acceptance rate of minimally-invasive procedures, the presence of advantageous reimbursement policies, and the increasing elderly population.
Therefore, the demand for cardiovascular ablation catheters is increasing due to the rising prevalence of heart-related disorders. Also, the presence of leading companies in the nation is supporting the sales of cardiac catheters.
To compete with the current products, major market players in the nation are creating unique innovations and products for the cardiac catheter market, while others are buying out and forming partnerships with other businesses that are trending on the market.
“Rising Cases of Heart-related Disorders”
Germany is the leading marketplace for cardiac catheter manufacturers in the European region. This can be attributed to the aspects such as the high rate of heart diagnosis, availability of efficient and effective government healthcare facilities, and awareness of heart health.
According to recent studies, Germany is among the countries with the highest rates of heart disease; it is ranked eighth globally for the number of deaths attributable to heart disease.
This is more exorbitant than the rates in the United States and the United Kingdom combined. In Germany, heart-related disorders are the most prevalent and the leading cause of death.
Thus, the above-mentioned factors are increasing the rate of catheterization and cardiovascular interventions in the nation, which subsequently is driving sales of cardiac catheters.
“High Percentage of Senior Population Increasing Cases of Cardiac Conditions”
In Japan, it is estimated that individuals often live to be 100 years old and the prevalence rate of cardiovascular disorders rises with age. Thus, this factor is boosting the demand for cardiovascular catheters in the nation. Also, the increasing cases of heart failure in Japan are supporting sales growth.
Furthermore, growing marketing activities by the major market players are anticipated to fuel sales growth in Japan.
Such distribution alliances are promoting the sales of cardiovascular devices in Japan.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Hospitals Handsomely Dominate Sales of Cardiac Catheters”
Based on end user, the cardiovascular catheters are segmented into hospitals, clinics, and ambulatory surgical centers. Demand for cardiac catheters from hospitals is expected to increase at a healthy CAGR during the forecast period.
A coronary heart disease is a common form of CVDs, the rising prevalence of heart-related disorders worldwide is increasing the rate of hospitalization, which is further rising the demand for cardiac catheters. Factors such as the availability of advanced healthcare systems, the presence of skilled medical professionals, and reimbursement policies are supporting sales growth.
Some of the key players in the cardiovascular catheters market are AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Medtronic PLC, and Merit Medical Systems, Inc.
The leading companies in the cardiovascular catheters market are focusing on the diversification of product portfolios by adopting several marketing strategies such as improving quality control, product standards, and high investments in R&D. They are also concentrating on regional business expansion by improving local supply chain management systems.
New Developments :
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Buy NowGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
- Related Reports -
Global demand for cardiovascular catheters is expected to increase at a CAGR of 7% from 2023 to 2033.
The global cardiovascular catheters market is currently valued at US$ 21.44 billion.
Worldwide sales of cardiovascular catheters are projected to reach US$ 42.18 billion by 2033.
North America accounts for a dominant position in the global market for cardiovascular catheters.
Hospitals hold a significant share of the market for cardiovascular catheters.